Available IPD datapackage for study 'ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease'

Vivli 2026 Dataset Open access

Read full text
Authors: J.H. Johnson
DOI: 10.25934/pr00004623.1
Cited by: 0

Abstract

A study of infliximab in patients with Fistulizing Crohn's Disease

Publication details

Journal / source
Vivli
Publication date
7 January 2026
Language
EN
Document type
Dataset